4.3 Article

Effect of Long Noncoding RNA HULC on Proliferation, Migration, and Invasion of Osteosarcoma Cells

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

miR-96-5p is the tumor suppressor in osteosarcoma via targeting SYK

Taiping Wang et al.

Summary: The study identified that MiR-96-5p is upregulated in osteosarcoma tissues and cells, and can inhibit proliferation, adhesion, and migration of osteosarcoma cells while promoting apoptosis. Furthermore, MiR-96-5p targets SYK to exert its function in osteosarcoma treatment.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Oncology

Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer

Rui-Qi Wang et al.

Summary: lnc-GAN1 is downregulated in NSCLC tissues and associated with poor prognosis; it acts as a tumor suppressor by sponging and inhibiting miR-26a-5p to upregulate PTEN, providing a potential prognostic biomarker and treatment target for NSCLC.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Oncology

lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions

Evan M. McCabe et al.

Summary: The epithelial to mesenchymal transition (EMT) is a cellular process crucial in embryogenesis, where cancer stem cells (CSCs) play a role by differentiating and undergoing EMT. Long noncoding RNAs (lncRNAs) also have a role in CSCs and EMT, with the potential to serve as biomarkers and therapeutic targets in cancer progression.

SEMINARS IN CANCER BIOLOGY (2021)

Review Medicine, Research & Experimental

Role of lncRNA LUCAT1 in cancer

Ce Xing et al.

Summary: Long non-coding RNAs (lncRNAs) regulate gene expression by interacting with protein, RNA, and DNA, and abnormalities in lncRNAs play a role in tumorigenesis. Specifically, LUCAT1 is highly expressed in various malignant tumors and regulates tumor proliferation and migration through different mechanisms, making it a potential prognostic biomarker and therapeutic target for cancer.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Chemistry, Multidisciplinary

LncRNA Lnc-APUE is Repressed by HNF4α and Promotes G1/S Phase Transition and Tumor Growth by Regulating MiR-20b/E2F1 Axis

Song-Yang Li et al.

Summary: A novel long noncoding RNA called lnc-APUE was discovered, which accelerates cell proliferation in various types of cancer by binding to miR-20b and enhancing E2F1 expression. This study revealed a new axis involving HNF4 alpha/lnc-APUE/miR-20b/E2F1 in tumor cells, where HNF4 alpha repression leads to increased lnc-APUE expression and subsequent promotion of cell cycle progression and tumor growth.

ADVANCED SCIENCE (2021)

Article Medicine, Research & Experimental

LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis

Tao Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Pathology

Osteosarcoma: A comprehensive review of management and treatment strategies

Farzaneh Jafari et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2020)

Review Biochemistry & Molecular Biology

Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies

Ingrid Lilienthal et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

The PTEN-PI3K Axis in Cancer

Antonella Papa et al.

BIOMOLECULES (2019)

Article Biochemistry & Molecular Biology

LncRNA HULC promotes lung squamous cell carcinoma by regulating PTPRO via NF-κB

Yang Xu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Medical Laboratory Technology

LncRNA HOXA-AS2 and its molecular mechanisms in human cancer

Jicai Wang et al.

CLINICA CHIMICA ACTA (2018)

Article Biochemistry & Molecular Biology

Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a

Xiaoru Xin et al.

MOLECULAR CANCER (2018)

Article Oncology

Osteosarcoma of the jaw: Challenges in the diagnosis and treatment

Mohamed Atef ElKordy et al.

JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2018)

Review Cell Biology

HULC: an oncogenic long non-coding RNA in human cancer

Xin Yu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Review Pharmacology & Pharmacy

PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation

Var Ruchi Sharma et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Review Genetics & Heredity

Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer

Yiwen Fang et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2016)

Article Biotechnology & Applied Microbiology

Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma

Hui Xie et al.

BIOMED RESEARCH INTERNATIONAL (2013)